SUBCLINICAL HYPOTHYROIDISM - TO TREAT OR NOT TO TREAT, THAT IS THE QUESTION

被引:16
作者
FRANKLYN, J
机构
关键词
D O I
10.1111/j.1365-2265.1995.tb02615.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:443 / 444
页数:2
相关论文
共 16 条
[2]   THYROID-HORMONE THERAPY AND THE SKELETON - COMMENTARY [J].
COMPSTON, JE .
CLINICAL ENDOCRINOLOGY, 1993, 39 (05) :519-520
[3]   L-THYROXINE THERAPY IN SUBCLINICAL HYPOTHYROIDISM - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
COOPER, DS ;
HALPERN, R ;
WOOD, LC ;
LEVIN, AA ;
RIDGWAY, EC .
ANNALS OF INTERNAL MEDICINE, 1984, 101 (01) :18-24
[4]   RISK-FACTORS FOR HIP FRACTURE IN WHITE WOMEN [J].
CUMMINGS, SR ;
NEVITT, MC ;
BROWNER, WS ;
STONE, K ;
FOX, KM ;
ENSRUD, KE ;
CAULEY, JC ;
BLACK, D ;
VOGT, TM .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (12) :767-773
[5]   THE SIGNIFICANCE OF TSH VALUES MEASURED IN A SENSITIVE ASSAY IN THE FOLLOW-UP OF HYPERTHYROID PATIENTS TREATED WITH RADIOIODINE [J].
DAVIES, PH ;
FRANKLYN, JA ;
DAYKIN, J ;
SHEPPARD, MC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (05) :1189-1194
[6]  
ENGLER H, 1993, CLIN CHEM, V39, P2466
[7]   BONE-MINERAL DENSITY IN THYROXINE TREATED FEMALES WITH OR WITHOUT A PREVIOUS HISTORY OF THYROTOXICOSIS [J].
FRANKLYN, J ;
BETTERIDGE, J ;
HOLDER, R ;
DAYKIN, J ;
LILLEY, J ;
SHEPPARD, M .
CLINICAL ENDOCRINOLOGY, 1994, 41 (04) :425-432
[8]   THYROXINE REPLACEMENT THERAPY AND CIRCULATING LIPID CONCENTRATIONS [J].
FRANKLYN, JA ;
DAYKIN, J ;
BETTERIDGE, J ;
HUGHES, EA ;
HOLDER, R ;
JONES, SR ;
SHEPPARD, MC .
CLINICAL ENDOCRINOLOGY, 1993, 38 (05) :453-459
[9]   SUPPRESSIVE DOSES OF THYROXINE DO NOT ACCELERATE AGE-RELATED BONE LOSS IN LATE POSTMENOPAUSAL WOMEN [J].
FUJIYAMA, K ;
KIRIYAMA, T ;
ITO, M ;
KIMURA, H ;
ASHIZAWA, K ;
TSURUTA, M ;
NAGAYAMA, Y ;
VILLADOLID, MC ;
YOKOYAMA, N ;
NAGATAKI, S .
THYROID, 1995, 5 (01) :13-17
[10]   ELEVATED SERUM LIPOPROTEIN(A) IN SUBCLINICAL HYPOTHYROIDISM [J].
KUNG, AWC ;
PANG, RWC ;
JANUS, ED .
CLINICAL ENDOCRINOLOGY, 1995, 43 (04) :445-449